EVOQ REMEDIES-MT Profit & Loss Annual

Trade
BSE: 543500 | NSE: - | ISIN: INE0JVD01011 | Sector: Biotechnology & Drugs
11.25 -0.09 (-0.79%)Updated : 24 Apr 2024
Fiscal Period2023202220212020
Period End DateMar 23Mar 22Mar 21Mar 20
Revenue 20.3916.7810.029.07
Total Revenue 20.3916.7810.029.07
Costof Revenue Total 19.3313.777.859.05
Gross Profit 1.063.012.170.03
Selling/ General/ Admin Expenses Total 0.200.180.010.01
Depreciation/ Amortization 0.000.000.000.00
Other Operating Expenses Total 4.591.371.210.01
Total Operating Expense 24.1315.329.079.07
Operating Income -3.741.460.950.00
Other Net 6.020.000.00-
Net Income Before Taxes 2.281.460.950.00
Provisionfor Income Taxes 0.670.370.240.00
Net Income After Taxes 1.621.090.720.00
Net Income Before Extra Items 1.621.090.720.00
Net Income 1.621.090.720.00
Income Availableto Com Excl Extra Ord 1.621.090.720.00
Income Availableto Com Incl Extra Ord 1.621.090.720.00
Diluted Net Income 1.621.090.720.00
Diluted Weighted Average Shares 1.361.361.361.36
Diluted EPS Excluding Extra Ord Items 1.190.800.530.00
Diluted Normalized EPS 1.190.800.530.00
Interest Inc( Exp) Net- Non- Op Total --0.050.000.00
Total Adjustmentsto Net Income -0.00--
DPS- Common Stock Primary Issue -0.000.000.00
Unusual Expense( Income) ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
165.50+4.40(2.73%)
1,843.05+29.80(1.64%)
1,186.10-14.00 (-1.17%)
HomeMarketsPremiumFor youGet App